FilingPulse

KDNY insider filings

CHINOOK THERAPEUTICS, INC. — 26 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-08-11. Screen KDNY transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for KDNY between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.

Recent insider filings — CHINOOK THERAPEUTICS, INC.

FiledFormInsiderReported transactionsSource
2023-08-114Thomas Dolca — DirectorDisposition to issuer (D): 13,300 · Disposition to issuer (D): 23,522 (derivative) @ $25.23 · Disposition to issuer (D): 5,948 (derivative) @ $23.19 · Disposition to issuer (D): 13,300 (derivative) @ $26.12EDGAR
2023-08-114Oxtoby Andrew — Chief Commercial OfficerDisposition to issuer (D): 160,000 (derivative) @ $18.18 · Disposition to issuer (D): 40,000 (derivative)EDGAR
2023-08-114Krishnan Mahesh — DirectorDisposition to issuer (D): 1,275 · Disposition to issuer (D): 26,600 (derivative) @ $23.26 · Disposition to issuer (D): 4,401 (derivative)EDGAR
2023-08-114King Andrew James — Chief Scientific OfficerDisposition to issuer (D): 19,157 · Disposition to issuer (D): 43,047 (derivative) @ $39.65 · Disposition to issuer (D): 73,047 (derivative) @ $39.58 · Disposition to issuer (D): 89,545 (derivative) @ $25.23 · Disposition to issuer (D): 60,000 (derivative) @ $24.86 · Disposition to issuer (D): 21,500 (derivative) @ $22.41 · +8 moreEDGAR
2023-08-114Frohlich Tom — Chief Operating OfficerDisposition to issuer (D): 150,777 · Disposition to issuer (D): 43,847 (derivative) @ $39.58 · Disposition to issuer (D): 119,793 (derivative) @ $25.23 · Disposition to issuer (D): 60,000 (derivative) @ $24.86 · Disposition to issuer (D): 30,000 (derivative) @ $22.41 · Disposition to issuer (D): 100,000 (derivative) @ $27.10 · +6 moreEDGAR
2023-08-114Jerel Davis — DirectorDisposition to issuer (D): 447,013 · Disposition to issuer (D): 2,105,107 · Disposition to issuer (D): 719,104 · Disposition to issuer (D): 210,996 · Disposition to issuer (D): 23,522 (derivative) @ $25.23 · Disposition to issuer (D): 5,948 (derivative) @ $23.19 · +1 moreEDGAR
2023-08-114Azelby Robert — DirectorDisposition to issuer (D): 28,200 (derivative) @ $18.40 · Disposition to issuer (D): 7,000 (derivative)EDGAR
2023-08-114Greenman William Mariner — DirectorDisposition to issuer (D): 23,643 · Disposition to issuer (D): 3,600 (derivative) @ $35 · Disposition to issuer (D): 8,000 (derivative) @ $0 · Disposition to issuer (D): 2,600 (derivative) @ $0 · Disposition to issuer (D): 2,600 (derivative) @ $0 · Disposition to issuer (D): 4,000 (derivative) @ $7 · +5 moreEDGAR
2023-08-114AKKARAJU SRINIVAS — DirectorDisposition to issuer (D): 3,300 · Disposition to issuer (D): 5,161,888 · Disposition to issuer (D): 23,522 (derivative) @ $25.23 · Disposition to issuer (D): 5,948 (derivative) @ $23.19 · Disposition to issuer (D): 13,300 (derivative) @ $26.12EDGAR
2023-08-114GRIFFIN MICHELLE RENEE — DirectorDisposition to issuer (D): 3,300 · Disposition to issuer (D): 23,522 (derivative) @ $25.23 · Disposition to issuer (D): 5,948 (derivative) @ $23.19 · Disposition to issuer (D): 13,300 (derivative) @ $26.12EDGAR
2023-08-114DOBMEIER ERIC — President, CEO, DirectorDisposition to issuer (D): 301,138 · Disposition to issuer (D): 353,358 (derivative) @ $39.65 · Disposition to issuer (D): 313,555 (derivative) @ $39.58 · Disposition to issuer (D): 271,647 (derivative) @ $25.23 · Disposition to issuer (D): 178,600 (derivative) @ $24.86 · Disposition to issuer (D): 300,000 (derivative) @ $27.10 · +6 moreEDGAR
2023-08-114BJERKHOLT ERIC — Chief Financial OfficerDisposition to issuer (D): 39,371 · Disposition to issuer (D): 144,787 (derivative) @ $26.02 · Disposition to issuer (D): 21,501 (derivative) @ $24.86 · Disposition to issuer (D): 88,000 (derivative) @ $27.10 · Disposition to issuer (D): 84,000 (derivative) @ $14.73 · Disposition to issuer (D): 16,415 (derivative) · +4 moreEDGAR
2023-08-014King Andrew James — Chief Scientific OfficerOption exercise (M): 3,333 · Sale (S): 1,168 @ $39.03 · Option exercise (M): 3,333 (derivative) @ $0EDGAR
2023-05-314Haghighat Ross — DirectorOption exercise (M): 3,300 · Option exercise (M): 3,300 (derivative) @ $0EDGAR
2023-05-314Jerel Davis — DirectorOption exercise (M): 3,300 · Option exercise (M): 3,300 (derivative) @ $0EDGAR
2023-05-314Thomas Dolca — DirectorOption exercise (M): 3,300 · Option exercise (M): 3,300 (derivative) @ $0EDGAR
2023-05-314Greenman William Mariner — DirectorOption exercise (M): 3,300 · Sale (S): 1,155 @ $23.30 · Option exercise (M): 3,300 (derivative) @ $0EDGAR
2023-05-314AKKARAJU SRINIVAS — DirectorOption exercise (M): 3,300 · Option exercise (M): 3,300 (derivative) @ $0EDGAR
2023-05-314GRIFFIN MICHELLE RENEE — DirectorOption exercise (M): 3,300 · Option exercise (M): 3,300 (derivative) @ $0EDGAR
2023-04-264DOBMEIER ERIC — President, CEO, DirectorOption exercise (M): 25,000 @ $0.42 · Sale (S): 23,800 @ $21.58 · Sale (S): 1,200 @ $22.26 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2023-04-194Jerel Davis — DirectorSale (S): 295,808 @ $20.75EDGAR
2023-04-124Azelby Robert — DirectorGrant/award (A): 28,200 (derivative) @ $0 · Grant/award (A): 7,000 (derivative) @ $0EDGAR
2023-04-054King Andrew James — Chief Scientific OfficerOption exercise (M): 2,500 @ $0.35 · Sale (S): 5,000 @ $23.34 · Option exercise (M): 2,500 (derivative) @ $0EDGAR
2023-04-044Krishnan Mahesh — DirectorOption exercise (M): 2,199 · Sale (S): 924 @ $23.01 · Option exercise (M): 2,199 (derivative) @ $0EDGAR
2023-03-034Jerel Davis — DirectorSale (S): 240,000 @ $22.75 · Sale (S): 123,249 @ $22.75 · Sale (S): 36,751 @ $22.75EDGAR
2023-03-024Oxtoby Andrew — Chief Commercial OfficerGrant/award (A): 160,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0EDGAR

Recent 8-K events — CHINOOK THERAPEUTICS, INC.

FiledFormItems reportedSource
2023-08-118-K1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits		EDGAR
2023-08-038-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2023-07-288-K8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2023-06-208-K8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2023-06-158-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders		EDGAR
2023-06-128-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2023-06-128-K8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2023-05-098-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2023-04-138-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2023-03-138-K7.01 — Regulation FD DisclosureEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=KDNY returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →